Role of viral infections in the development and exacerbation of asthma in children
- PMID: 28987219
- PMCID: PMC7172811
- DOI: 10.1016/j.jaci.2017.08.003
Role of viral infections in the development and exacerbation of asthma in children
Abstract
Viral infections are closely linked to wheezing illnesses in children of all ages. Respiratory syncytial virus (RSV) is the main causative agent of bronchiolitis, whereas rhinovirus (RV) is most commonly detected in wheezing children thereafter. Severe respiratory illness induced by either of these viruses is associated with subsequent development of asthma, and the risk is greatest for young children who wheeze with RV infections. Whether viral illnesses actually cause asthma is the subject of intense debate. RSV-induced wheezing illnesses during infancy influence respiratory health for years. There is definitive evidence that RSV-induced bronchiolitis can damage the airways to promote airway obstruction and recurrent wheezing. RV likely causes less structural damage and yet is a significant contributor to wheezing illnesses in young children and in the context of asthma. For both viruses, interactions between viral virulence factors, personal risk factors (eg, genetics), and environmental exposures (eg, airway microbiome) promote more severe wheezing illnesses and the risk for progression to asthma. In addition, allergy and asthma are major risk factors for more frequent and severe RV-related illnesses. Treatments that inhibit inflammation have efficacy for RV-induced wheezing, whereas the anti-RSV mAb palivizumab decreases the risk of severe RSV-induced illness and subsequent recurrent wheeze. Developing a greater understanding of personal and environmental factors that promote more severe viral illnesses might lead to new strategies for the prevention of viral wheezing illnesses and perhaps reduce the subsequent risk for asthma.
Keywords: Asthma; bronchiolitis; child; exacerbation; respiratory syncytial virus; rhinovirus; virus; wheeze; wheezing.
Copyright © 2017. Published by Elsevier Inc.
Figures
![Fig 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7172811/bin/gr1_lrg.gif)
![Fig 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7172811/bin/gr2_lrg.gif)
![Fig 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7172811/bin/gr3_lrg.gif)
Similar articles
-
Role of viruses in asthma.Semin Immunopathol. 2020 Feb;42(1):61-74. doi: 10.1007/s00281-020-00781-5. Epub 2020 Jan 27. Semin Immunopathol. 2020. PMID: 31989228 Free PMC article. Review.
-
Rhinovirus-induced bronchiolitis and asthma development.Pediatr Allergy Immunol. 2011 Jun;22(4):350-5. doi: 10.1111/j.1399-3038.2011.01170.x. Pediatr Allergy Immunol. 2011. PMID: 21535176 Review.
-
Viral respiratory infection and the link to asthma.Pediatr Infect Dis J. 2008 Oct;27(10 Suppl):S97-103. doi: 10.1097/INF.0b013e318168b718. Pediatr Infect Dis J. 2008. PMID: 18820588 Free PMC article.
-
Association of Rhinovirus C Bronchiolitis and Immunoglobulin E Sensitization During Infancy With Development of Recurrent Wheeze.JAMA Pediatr. 2019 Jun 1;173(6):544-552. doi: 10.1001/jamapediatrics.2019.0384. JAMA Pediatr. 2019. PMID: 30933255 Free PMC article.
-
Detection of Respiratory Syncytial Virus or Rhinovirus Weeks After Hospitalization for Bronchiolitis and the Risk of Recurrent Wheezing.J Infect Dis. 2021 Feb 3;223(2):268-277. doi: 10.1093/infdis/jiaa348. J Infect Dis. 2021. PMID: 32564083 Free PMC article.
Cited by
-
[Urolithin A alleviates respiratory syncytial virus-induced lung infection in neonatal mice by activating miR-136-mediated Sirt1 signaling].Nan Fang Yi Ke Da Xue Xue Bao. 2024 Jul 20;44(7):1370-1381. doi: 10.12122/j.issn.1673-4254.2024.07.17. Nan Fang Yi Ke Da Xue Xue Bao. 2024. PMID: 39051083 Free PMC article. Chinese.
-
A critical analysis of the effect of OM-85 for the prevention of recurrent respiratory tract infections or wheezing/asthma from systematic reviews with meta-analysis.Pediatr Allergy Immunol. 2024 Jul;35(7):e14186. doi: 10.1111/pai.14186. Pediatr Allergy Immunol. 2024. PMID: 39016384
-
Prevalence of human respiratory pathogens and associated mucosal cytokine levels in young children and adults: a cross-sectional observational study in the Netherlands during the winter of 2012/2013.Pathog Dis. 2024 Feb 7;82:ftae010. doi: 10.1093/femspd/ftae010. Pathog Dis. 2024. PMID: 38714349 Free PMC article.
-
Determinants of immunoglobulin G responses to respiratory syncytial virus and rhinovirus in children and adults.Front Immunol. 2024 Mar 4;15:1355214. doi: 10.3389/fimmu.2024.1355214. eCollection 2024. Front Immunol. 2024. PMID: 38500884 Free PMC article.
-
Environmental Interventions for Preventing Atopic Diseases.Curr Allergy Asthma Rep. 2024 May;24(5):233-251. doi: 10.1007/s11882-024-01141-1. Epub 2024 Mar 16. Curr Allergy Asthma Rep. 2024. PMID: 38492159 Review.
References
-
- Taussig L.M., Wright A.L., Holberg C.J., Halonen M., Morgan W.J., Martinez F.D. Tucson children's respiratory study: 1980 to present. J Allergy Clin Immunol. 2003;111:661–675. - PubMed
-
- Meissner H.C. Viral bronchiolitis in children. N Engl J Med. 2016;374:1793–1794. - PubMed
-
- Lai C.K., Beasley R., Crane J., Foliaki S., Shah J., Weiland S. Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC) Thorax. 2009;64:476–483. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical